Preventive Efficacy of Tenofovir/Emtricitabine Against Severe Acute Respiratory Syndrome Coronavirus 2 Among Pre-Exposure Prophylaxis Users

BACKGROUND: The preventive effect that tenofovir/emtricitabine (FTC) could have against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human immunodeficiency virus-negative people is unknown. The objective of this study was to analyze the seroprevalence and clinical manifestations o...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Open Forum Infect Dis
Главные авторы: Ayerdi, Oskar, Puerta, Teresa, Clavo, Petunia, Vera, Mar, Ballesteros, Juan, Fuentes, Manuel Enrique, Estrada, Vicente, Rodríguez, Carmen, Del Romero, Jorge
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Major Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7543639/
https://ncbi.nlm.nih.gov/pubmed/33200081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa455
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы